CoChat

Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer

Douillard, Jean-Yves, Siena, Salvatore, Peeters, Marc, Koukakis, Reija, Terwey, Jan-Henrik, Tabernero, Josep · 2015 · European Journal of Cancer
Cited by 67

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2015.03.026

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 19

  1. Siegel, 2012, Cancer statistics, 2012, CA Cancer J Clin, 62, 10, 10.3322/caac.20138 · DOI · Paper page
  2. Chiappa, 2009, The management of colorectal liver metastases: expanding the role of hepatic resection in the age of multimodal therapy, Crit Rev Oncol Hematol, 72, 65, 10.1016/j.critrevonc.2008.11.003 · DOI
  3. Ksienski, 2010, Patterns of referral and resection among patients with liver-only metastatic colorectal cancer (MCRC), Ann Surg Oncol, 17, 3085, 10.1245/s10434-010-1304-9 · DOI
  4. Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Natl Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 · DOI · Paper page
  5. Piessevaux, 2013, Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab, J Clin Oncol, 31, 3764, 10.1200/JCO.2012.42.8532 · DOI · Paper page
  6. Giessen, 2013, Early tumor shrinkage in metastatic colorectal cancer: retrospective analysis from an irinotecan-based randomized first-line trial, Cancer Sci, 104, 718, 10.1111/cas.12148 · DOI
  7. Modest, 2013, Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trial, Acta Oncol, 52, 956, 10.3109/0284186X.2012.752580 · DOI
  8. Suzuki, 2012, The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy, Ann Oncol, 23, 948, 10.1093/annonc/mdr350 · DOI
  9. Douillard, 2010, Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study, J Clin Oncol, 28, 4697, 10.1200/JCO.2009.27.4860 · DOI · Paper page
  10. Douillard, 2014, Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer, Ann Oncol, 25, 1346, 10.1093/annonc/mdu141 · DOI · Paper page
  11. Rosenbaum, 1983, The central role of the propensity score in observational studies for causal effects, Biometrika, 70, 41, 10.1093/biomet/70.1.41 · DOI · Paper page
  12. Heinemann, 2014, Independent radiological evaluation of objective response, early tumour shrinkage, and depth of response in FIRE-3 (AIO KRK-0306), Ann Oncol, 25, ii117, 10.1093/annonc/mdu193.30 · DOI
  13. Mansmann, 2012, Improved early prediction of individual prognosis for patients with mCRC: Joint modelling of tumor shrinkage with volume data for PFS and OS, J Clin Oncol, 30
  14. Mansmann, 2012, Deepness of response: a quantitative analysis of its impact on post-progression survival time after first-line treatment in patients with mCRC, J Clin Oncol, 30
  15. Grothey, 2008, Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107, J Clin Oncol, 26, 183, 10.1200/JCO.2007.13.8099 · DOI · Paper page
  16. Douillard JY, Peeters M, Rong A et al. Effect of post-protocol anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) therapy on survival outcomes in patients with wild-type (WT) KRAS metastatic colorectal cancer (mCRC) treated with panitumumab (pmab) plus chemotherapy. In: 14th World Congress on Gastrointestinal Cancer; 12 Jun 27; 2012. · doi:10.1016/s0923-7534(20)33181-1
  17. Omurlu, 2009, Comparison of Bayesian survival analysis and Cox regression analysis in simulated and breast cancer data sets, Expert Syst Appl, 36, 11341, 10.1016/j.eswa.2009.03.058 · doi:10.1016/j.eswa.2009.03.058
  18. Stein, 2013, Survival prediction in everolimus-treated patients with metastatic renal cell carcinoma incorporating tumor burden response in the RECORD-1 Trial, Eur Urol, 64, 994, 10.1016/j.eururo.2012.11.032 · DOI
  19. Sullivan, 2013, The imaging viewpoint: how imaging affects determination of progression-free survival, Clin Cancer Res, 19, 2621, 10.1158/1078-0432.CCR-12-2936 · DOI

Cited by

See all 67

Metadata

Authors
Douillard, J.-Y., Siena, S., Peeters, M., Koukakis, R., Terwey, J.-H., & Tabernero, J.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2015-07
Volume
51
Issue
10
Pages
1231-1242
ISSN
0959-8049
Cited by
67
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer. https://app.cochat.ai/papers/10.1016/j.ejca.2015.03.026
The paper
Douillard, J.-Y., Siena, S., Peeters, M., Koukakis, R., Terwey, J.-H., & Tabernero, J. (2015). Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2015.03.026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.